nsv4754021
- Organism: Homo sapiens
- Study:nstd199 (Quan et al. 2021)
- Variant Type:inversion
- Method Type:Sequencing
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:60,330
- Publication(s):Quan et al. 2021
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 679 SVs from 53 studies. See in: genome view
Overlapping variant regions from other studies: 669 SVs from 53 studies. See in: genome view
Variant Region Placement Information
| Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop |
|---|---|---|---|---|---|---|---|---|---|
| nsv4754021 | Remapped | Good | GRCh38.p12 | Primary Assembly | First Pass | NC_000023.11 | ChrX | 154,335,917 | 154,396,246 |
| nsv4754021 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000023.10 | ChrX | 153,564,267 | 153,624,587 |
Variant Call Information
| Variant Call ID | Type | Method | Analysis |
|---|---|---|---|
| nssv16294962 | inversion | Sequencing | Split read mapping |
Variant Call Placement Information
| Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
|---|---|---|---|---|---|---|---|---|---|
| nssv16294962 | Remapped | Good | NC_000023.11:g.154 335917_154396246in v | GRCh38.p12 | First Pass | NC_000023.11 | ChrX | 154,335,917 | 154,396,246 |
| nssv16294962 | Submitted genomic | NC_000023.10:g.153 564267_153624587in v | GRCh37 (hg19) | NC_000023.10 | ChrX | 153,564,267 | 153,624,587 |